| 2024-01-08 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Scientific Officer | 2,275 0.0025% | $28.87 | $65,682 | -14.91% | |
| 2024-01-03 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Scientific Officer | 5,532 0.0062% | $29.46 | $162,973 | -12.78% | |
| 2023-01-05 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Scientific Officer | 2,330 0.0026% | $38.48 | $89,659 | -2.68% | |
| 2023-01-04 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Scientific Officer | 2,508 0.0027% | $37.21 | $93,323 | -3.48% | |
| 2022-01-01 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Scientific Officer | 1,148 0.0015% | $112.25 | $128,863 | ||
| 2021-08-30 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Scientific Officer | 97,000 0.1324% | $154.83 | $15.02M | -48.07% | |
| 2021-08-04 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Scientific Officer | 26,000 0.0332% | $138.24 | $3.59M | -37.8% |